Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Bentley Systems
BSY
$12.4B
| $13.3M | 0.02% |
443,521
-10,473
| -2% | -$341K |
2025 Q1
5 quarters
|
|
602
Allegion
ALLE
$15.9B
| $13.2M | 0.02% |
93,835
-2,058
| -2% | -$280K |
2017 Q4
34 quarters
|
|
603
Atmos Energy
ATO
$29.1B
| $13M | 0.02% |
75,700
+21,148
| +39% | +$3.79M |
2025 Q3
3 quarters
|
|
604
Verra Mobility
VRRM
$426M
| $13M | 0.02% |
+3,050,015
| New | +$32.2M |
2026 Q2
0 quarters
|
|
605
Aquestive Therapeutics
AQST
$488M
| $12.9M | 0.02% |
3,112,561
+172,222
| +6% | +$725K |
2025 Q3
3 quarters
|
|
606
Bio-Techne
TECH
$11.4B
| $12.9M | 0.02% |
183,137
-121,974
| -40% | -$6.59M |
2025 Q3
3 quarters
|
|
607
Masco
MAS
$15.5B
| $12.9M | 0.02% |
158,676
-8,926
| -5% | -$623K |
2013 Q2
52 quarters
|
|
608
Neurocrine Biosciences
NBIX
$14.9B
| $12.9M | 0.02% |
76,569
+67,841
| +777% | +$10.1M |
2017 Q2
36 quarters
|
|
609
Berkshire Hathaway Class B
BRK.B
$1.16T
| $12.8M | 0.02% |
25,663
-14,875
| -37% | -$7.15M |
2013 Q2
52 quarters
|
|
610
Universal Technical Institute
UTI
$1.25B
| $12.8M | 0.02% |
300,000
| – | – |
2023 Q4
10 quarters
|
|
611
Waste Management
WM
$92.8B
| $12.8M | 0.02% |
57,532
+11,137
| +24% | +$2.48M |
2013 Q2
52 quarters
|
|
612
Delta Air Lines
DAL
$52.7B
| $12.6M | 0.02% |
134,179
-117,672
| -47% | -$8.88M |
2013 Q2
52 quarters
|
|
613
Victory Capital Holdings
VCTR
$6.8B
| $12.6M | 0.02% |
149,479
-29,671
| -17% | -$2.39M |
2023 Q3
11 quarters
|
|
614
Cushman & Wakefield Ltd
CWK
$3.12B
| $12.6M | 0.02% |
937,997
+28,812
| +3% | +$387K |
2021 Q3
19 quarters
|
|
615
Danaher
DHR
$163B
| $12.5M | 0.02% |
65,680
+3,993
| +6% | +$725K |
2013 Q2
52 quarters
|
|
616
Amkor Technology
AMKR
$9.8B
| $12.5M | 0.02% |
145,017
-11,509
| -7% | -$820K |
2014 Q3
47 quarters
|
|
617
McKesson
MCK
$116B
| $12.5M | 0.02% |
16,532
-227
| -1% | -$180K |
2013 Q2
52 quarters
|
|
618
Apollo Global Management
APO
$68.4B
| $12.4M | 0.02% |
104,858
-49,985
| -32% | -$6.29M |
2022 Q1
17 quarters
|
|
619
Once Upon a Farm PBC
OFRM
$631M
| $12.3M | 0.02% |
600,000
| – | – |
2026 Q1
1 quarter
|
|
620
Intellia Therapeutics
NTLA
$1.75B
| $12.3M | 0.02% |
725,970
+357,353
| +97% | +$5M |
2020 Q2
24 quarters
|
|
621
Ferguson
FERG
$46.2B
| $12.2M | 0.02% |
51,439
+51,435
| +1,285,875% | +$12.4M |
2025 Q4
2 quarters
|
|
622
AutoZone
AZO
$51B
| $12.2M | 0.02% |
3,818
-1,387
| -27% | -$4.61M |
2013 Q2
52 quarters
|
|
623
Griffon
GFF
$4.58B
| $12.2M | 0.02% |
124,655
+10,948
| +10% | +$955K |
2023 Q3
11 quarters
|
|
624
Hinge Health
HNGE
$9.22B
| $12.2M | 0.02% |
+146,392
| New | +$7.95M |
2026 Q2
0 quarters
|
|
625
Vital Farms
VITL
$372M
| $12.1M | 0.02% |
1,044,039
+647,190
| +163% | +$7.21M |
2026 Q1
1 quarter
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.